Literature DB >> 8705771

Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.

J G Cleland1, S Ward, D Dutka, F Habib, M Impallomeni, I J Morton.   

Abstract

BACKGROUND: Plasma concentrations of atrial natriuretic peptide (ANP) are increased in patients with ventricular dysfunction and could have a diagnostic role in heart failure. ANP may be unstable after collection, however, limiting any practical diagnostic role.
METHODS: Blood samples were obtained from 18 patients with various conditions. Aliquots were either processed optimally or kept as blood or plasma at room temperature for 6-72 h before processing.
RESULTS: Concentrations of C-terminal ANP were lower in specimens kept as blood for 24 and 72 h (mean difference from control -43% and -76%, respectively, (P < 0.001) but N-terminal ANP (extracted) seemed to be stable under all conditions studied (-2% at 24 h and -7% at 72 h, not significant).
CONCLUSIONS: N-terminal ANP (extracted) is stable and potentially has a role in the diagnosis of heart failure in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705771      PMCID: PMC484320          DOI: 10.1136/hrt.75.4.410

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  ACE inhibitors and heart failure.

Authors:  J G Cleland
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

2.  Validity of clinical diagnosis of heart failure in primary health care.

Authors:  J Remes; H Miettinen; A Reunanen; K Pyörälä
Journal:  Eur Heart J       Date:  1991-03       Impact factor: 29.983

3.  Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population.

Authors:  T Wallén; S Landahl; T Hedner; J Hedner; C Hall
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

4.  Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure.

Authors:  F V Aguirre; A C Pearson; M K Lewen; M McCluskey; A J Labovitz
Journal:  Am J Cardiol       Date:  1989-05-01       Impact factor: 2.778

5.  Plasma atrial natriuretic peptide is unstable under most storage conditions.

Authors:  R A Nelesen; J E Dimsdale; M G Ziegler
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.

Authors:  A Lerman; R J Gibbons; R J Rodeheffer; K R Bailey; L J McKinley; D M Heublein; J C Burnett
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

7.  Trends in hospitalization for heart failure in Scotland 1980-1990.

Authors:  J McMurray; T McDonagh; C E Morrison; H J Dargie
Journal:  Eur Heart J       Date:  1993-09       Impact factor: 29.983

8.  Echocardiography in chronic heart failure in the community.

Authors:  N M Wheeldon; T M MacDonald; C J Flucker; A D McKendrick; D G McDevitt; A D Struthers
Journal:  Q J Med       Date:  1993-01

9.  Usefulness of M-mode echocardiography in the diagnosis of heart failure.

Authors:  J Remes; E Länsimies; K Pyörälä
Journal:  Cardiology       Date:  1991       Impact factor: 1.869

10.  Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

Authors:  A M Richards; G Tonolo; G D McIntyre; B J Leckie; J I Robertson
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

  10 in total
  6 in total

Review 1.  Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.

Authors:  H Krum; R Denver; A Tzanidis; P Martin
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

3.  Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.

Authors:  M Lough; J Cleland; J Langan; A Cowley; A Wade
Journal:  BMJ       Date:  1998-11-14

Review 4.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

5.  Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.

Authors:  C G Missouris; D E Ward; J B Eastwood; G A MacGregor
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

6.  Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.

Authors:  D R Murdoch; J Byrne; J J Morton; T A McDonagh; S D Robb; S Clements; I Ford; J J McMurray; H J Dargie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.